Alexion Pharma (ALXN) Tops Q2 EPS by 30c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
Tweet Send to a Friend
Alexion Pharma (NASDAQ: ALXN) reported Q2 EPS of $2.64, $0.30 better than the analyst estimate of $2.34. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
